A recent deep dive into the unraveling of Moderna by reporter Jason Mast is one of the most popular STAT stories of the year.

Exclusive: Arena Bioworks, the buzzy research institute that launched with $500 million to support a decade of scientific R&D ...

A deal with Lilly and Novo would be significant for the administration’s push for lower drug prices for Americans.

The new strategy shares themes with health secretary Robert F. Kennedy Jr.’s Make America Health Again agenda. He has called ...

We’re also continuing to track the fallout from all the recent FDA controversies.

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

In this edition of STAT's Health Tech newsletter: the latest on GLP-1 microdosing, AI for medical coding and more.

Metsera said Pfizer and Novo Nordisk both upped their bids to acquire the obesity startup, with Novo’s offer valuing the company for up to $10 billion.

Observers characterized the dismissals, policy reversals, and controversies at the FDA as a soap opera, total disarray, and potentially, unprincipled ...

Fewer pre-teens and adolescents are vaping nicotine these days than in previous years. But a study published yesterday in ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Sarepta Therapeutics delivered a disastrous third-quarter earnings performance. A long-delayed confirmatory clinical trial of ...